Literature DB >> 17030847

Adenovirus type 5 fiber knob domain has a critical role in fiber protein synthesis and encapsidation.

Petra Henning1,2, Emma Lundgren2, Mattias Carlsson2, Karolin Frykholm2, Jenny Johannisson2, Maria K Magnusson1,2, Erika Tång2, Laure Franqueville3, Saw See Hong3, Leif Lindholm2, Pierre Boulanger4,3.   

Abstract

Adenovirus serotype 5 (Ad5) vectors carrying knobless fibers designed to remove their natural tropism were found to have a lower fiber content than recombinant Ad5 with wild-type (WT) capsid, implying a role for the knob-coding sequence or/and the knob domain in fiber encapsidation. Experimental data using a variety of fiber gene constructs showed that the defect did not occur at the fiber mRNA level, but at the protein level. Knobless fiber proteins were found to be synthesized at a significant slower rate compared with knob-carrying fibers, and the trimerization process of knobless fibers paralleled their slow rate of synthesis. A recombinant Ad5 diploid for the fiber gene (referred to as Ad5/R7-ZZ(wt)/E1 : WT-fiber) was constructed to analyse the possible rescue of the knobless low-fiber-content phenotype by co-expression of WT fiber. Ad5/R7-ZZ(wt)/E1 : WT-fiber contained a knobless fiber gene in its natural location (L5) in the viral genome and an additional WT fiber gene in an ectopic position in E1. Knobless fiber was still synthesized at low levels compared with the co-expressed E1 : WT fiber and the recovery of the two fiber species in virus progeny reflected their respective amounts in the infected cells. Our results suggested that deletion of the fiber knob domain had a negative effect on the translation of the fiber mRNA and on the intracellular concentration of fiber protein. They also suggested that the knob control of fiber protein synthesis and encapsidation occurred as a cis effect, which was not modified by WT fiber protein provided in trans by the same Ad5 genome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030847     DOI: 10.1099/vir.0.81992-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

Review 1.  Current advances and future challenges in Adenoviral vector biology and targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Curr Gene Ther       Date:  2007-06       Impact factor: 4.391

2.  The effect of fiber truncations on the stability of adenovirus type 5.

Authors:  Grit Kupgan; Danielle C Hentges; Nathan J Muschinske; William D Picking; Wendy L Picking; Joshua D Ramsey
Journal:  Mol Biotechnol       Date:  2014-11       Impact factor: 2.695

3.  Unnatural amino acid incorporation onto adenoviral (Ad) coat proteins facilitates chemoselective modification and retargeting of Ad type 5 vectors.

Authors:  Partha Sarathi Banerjee; Philomena Ostapchuk; Patrick Hearing; Isaac Sheridan Carrico
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

4.  Chemoselective attachment of small molecule effector functionality to human adenoviruses facilitates gene delivery to cancer cells.

Authors:  Partha Sarathi Banerjee; Philomena Ostapchuk; Patrick Hearing; Isaac Carrico
Journal:  J Am Chem Soc       Date:  2010-10-06       Impact factor: 15.419

Review 5.  Oncolytic viruses: adenoviruses.

Authors:  Julia Niemann; Florian Kühnel
Journal:  Virus Genes       Date:  2017-07-12       Impact factor: 2.198

6.  Chemoselective modification of viral surfaces via bioorthogonal click chemistry.

Authors:  Frederick A Rubino; Yoon Hyeun Oum; Lakshmi Rajaram; Yanjie Chu; Isaac S Carrico
Journal:  J Vis Exp       Date:  2012-08-19       Impact factor: 1.355

7.  Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction.

Authors:  Stéphanie Corjon; Gaëlle Gonzalez; Petra Henning; Alexei Grichine; Leif Lindholm; Pierre Boulanger; Pascal Fender; Saw-See Hong
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

8.  Tropism-modification strategies for targeted gene delivery using adenoviral vectors.

Authors:  Lynda Coughlan; Raul Alba; Alan L Parker; Angela C Bradshaw; Iain A McNeish; Stuart A Nicklin; Andrew H Baker
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

9.  Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells.

Authors:  Xavier Bofill-De Ros; Eneko Villanueva; Cristina Fillat
Journal:  Oncotarget       Date:  2015-03-20

10.  Protein crystals in Adenovirus type 5-infected cells: requirements for intranuclear crystallogenesis, structural and functional analysis.

Authors:  Laure Franqueville; Petra Henning; Maria Magnusson; Emmanuelle Vigne; Guy Schoehn; Maria E Blair-Zajdel; Nagy Habib; Leif Lindholm; G Eric Blair; Saw See Hong; Pierre Boulanger
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.